- Home
- FURY vs GNTA Comparison
FURY vs GNTA Comparison
Compare FURY & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FURY
- GNTA
- Stock Information
- Founded
- FURY 2008
- GNTA 2014
- Country
- FURY Canada
- GNTA Italy
- Employees
- FURY N/A
- GNTA N/A
- Industry
- FURY Precious Metals
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FURY Basic Materials
- GNTA Health Care
- Exchange
- FURY Nasdaq
- GNTA Nasdaq
- Market Cap
- FURY 94.8M
- GNTA 81.2M
- IPO Year
- FURY N/A
- GNTA 2021
- Fundamental
- Price
- FURY $0.52
- GNTA $3.70
- Analyst Decision
- FURY Strong Buy
- GNTA Strong Buy
- Analyst Count
- FURY 1
- GNTA 1
- Target Price
- FURY $1.40
- GNTA $25.00
- AVG Volume (30 Days)
- FURY 223.4K
- GNTA 25.8K
- Earning Date
- FURY 08-11-2025
- GNTA 01-01-0001
- Dividend Yield
- FURY N/A
- GNTA N/A
- EPS Growth
- FURY N/A
- GNTA N/A
- EPS
- FURY N/A
- GNTA N/A
- Revenue
- FURY N/A
- GNTA N/A
- Revenue This Year
- FURY N/A
- GNTA N/A
- Revenue Next Year
- FURY N/A
- GNTA N/A
- P/E Ratio
- FURY N/A
- GNTA N/A
- Revenue Growth
- FURY N/A
- GNTA N/A
- 52 Week Low
- FURY $0.35
- GNTA $2.74
- 52 Week High
- FURY $0.59
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- FURY 50.91
- GNTA 47.31
- Support Level
- FURY $0.54
- GNTA $3.51
- Resistance Level
- FURY $0.58
- GNTA $3.90
- Average True Range (ATR)
- FURY 0.02
- GNTA 0.18
- MACD
- FURY -0.00
- GNTA 0.00
- Stochastic Oscillator
- FURY 30.78
- GNTA 39.14
About FURY Fury Gold Mines Limited
Fury Gold Mines Ltd is a Canadian-focused exploration and development company strategically positioned in three prolific mining regions: James Bay, Quebec; the Golden Triangle, British Columbia; and the Kitikmeot Region Nunavut. Its projects include Eau Claire, Homestake Ridge, Committee Bay, Eleonore South JV, and Gibson MacQuoid.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.